Aberrant CXCR4/CXCL12 signaling is associated with a variety of pathophysiological conditions including cancer metastasis, enhanced tumor growth, chronic inflammation, leukemia and altered immune responses9. The gene discussed is CXCL12; the disease is leukemia.